Global Meniere's Disease Drug Market -By Type ( Classic, Vestibular and Bilateral), Mechanism of Action (Antihistamines, Benzodiazepines, Antinausea, Diuretics, Antibiotics, Steroids and Others), Drugs (Meclizine, Diazepam, Prochlorperazine, Hydrochlorothiazide, Gentamicin, Dexamethasone and Others), Devices (Hearing Aid, Meniett device), Treatment (Medications, Therapy or Hearing Aids, Surgery), Route of Administration (Oral, Intravenous,
Intratympanic and Others), Distribution Channel (Online Pharmacy, Direct Tenders, Retailers and Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
in which FX-322 was observed to be well-tolerated following a single
intratympanic injection, with no serious adverse events.
Frequency recently completed a Phase 1/2 clinical study in the US in which FX-322 was observed to be well-tolerated following a single
intratympanic injection, with no serious adverse events.
Because of the potential systemic adverse effects associated with oral corticosteroids,
intratympanic (IT) corticosteroids have been advocated as an alternative treatment option.
when the vertigo becomes intractable, symptoms are disabling & patients had been unresponsive to medical therapy for at least 1 year, the disease may be treated by
intratympanic gentamicin injection as a last resort prior to surgical labyrinthectomy.
The speakers at Trinity Church Centre, Meole Brace, Shrewsbury, will be Andrew Scott, consultant ENT surgeon from Sath, who will give an update on
Intratympanic Therapies, with particular reference to Shropshire.
Clinical analysis of
intratympanic tympanosclerosis: etiology, ossicular chain findings, and hearing results of surgery.
Because of these side effects,
intratympanic (IT) route is getting increasingly popular.
These promising preclinical data, demonstrating the potential of
intratympanic BDNF to repair cochlear synaptopathy, an underlying cause of hearing loss including speech-in-noise hearing difficulty, are being presented as part of the Society for Neuroscience, or SfN.
The ENT recommended a series of
intratympanic steroid injections, which involves injecting the drug into the middle ear; the goal in her case was to reduce inflammation and diminish her hearing loss.
Evidence supports the use of
intratympanic steroid injections after primary treatment failure, although there is increasing interest in combining transtympanic perfusion with oral steroids for primary treatment.